138 related articles for article (PubMed ID: 7993803)
1. rh-erythropoietin stimulates immature reticulocyte release in man.
Major A; Bauer C; Breymann C; Huch A; Huch R
Br J Haematol; 1994 Jul; 87(3):605-8. PubMed ID: 7993803
[TBL] [Abstract][Full Text] [Related]
2. Optimal timing of repeated rh-erythropoietin administration improves its effectiveness in stimulating erythropoiesis in healthy volunteers.
Breymann C; Bauer C; Major A; Zimmermann R; Gautschi K; Huch A; Huch R
Br J Haematol; 1996 Feb; 92(2):295-301. PubMed ID: 8602988
[TBL] [Abstract][Full Text] [Related]
3. The effect of intravenous iron on the reticulocyte response to recombinant human erythropoietin.
Major A; Mathez-Loic F; Rohling R; Gautschi K; Brugnara C
Br J Haematol; 1997 Aug; 98(2):292-4. PubMed ID: 9266922
[TBL] [Abstract][Full Text] [Related]
4. Recombinant human erythropoietin in autologous blood donors: a dose-finding study.
Biesma DH; Kraaijenhagen RJ; Dalmulder J; Marx JJ; Van De Wiel A
Br J Haematol; 1994 Jan; 86(1):30-5. PubMed ID: 8011544
[TBL] [Abstract][Full Text] [Related]
5. Pharmacodynamics of recombinant human erythropoietin in murine bone marrow.
Bugelski PJ; Nesspor T; Volk A; O'Brien J; Makropoulos D; Shamberger K; Fisher PW; James I; Graden D; Capocasale RJ
Pharm Res; 2008 Feb; 25(2):369-78. PubMed ID: 17609863
[TBL] [Abstract][Full Text] [Related]
6. The quantification of reticulocyte maturation and neocytolysis in normal and erythropoietin stimulated rats.
Wiczling P; Krzyzanski W; Zychlińska N; Lewandowski K; Kaliszan R
Biopharm Drug Dispos; 2014 Sep; 35(6):330-40. PubMed ID: 24888906
[TBL] [Abstract][Full Text] [Related]
7. Early prediction of response to intravenous iron supplementation by reticulocyte haemoglobin content and high-fluorescence reticulocyte count in haemodialysis patients.
Chuang CL; Liu RS; Wei YH; Huang TP; Tarng DC
Nephrol Dial Transplant; 2003 Feb; 18(2):370-7. PubMed ID: 12543894
[TBL] [Abstract][Full Text] [Related]
8. Reticulocytes and reticulocyte enumeration.
Riley RS; Ben-Ezra JM; Goel R; Tidwell A
J Clin Lab Anal; 2001; 15(5):267-94. PubMed ID: 11574956
[No Abstract] [Full Text] [Related]
9. [Value of analyzing reticulocyte subpopulations in polycythemia].
Ataulfo González F; Bermejo A; Sánchez J; Anguita E; Villegas A
Sangre (Barc); 1997 Oct; 42(5):383-6. PubMed ID: 9424738
[TBL] [Abstract][Full Text] [Related]
10. Induction of fetal hemoglobin synthesis with recombinant human erythropoietin in anemic patients with heterozygous beta-thalassemia during pregnancy.
Breymann C; Fibach E; Visca E; Huettner C; Huch A; Huch R
J Matern Fetal Med; 1999; 8(1):1-7. PubMed ID: 10052837
[TBL] [Abstract][Full Text] [Related]
11. Reticulocyte subpopulations and reticulocyte maturity index (RMI) rise as body iron status falls.
Choi JW; Pai SH
Am J Hematol; 2001 Jun; 67(2):130-5. PubMed ID: 11343386
[TBL] [Abstract][Full Text] [Related]
12. Use of recombinant human erythropoietin in combination with parenteral iron in the treatment of postpartum anaemia.
Breymann C; Zimmermann R; Huch R; Huch A
Eur J Clin Invest; 1996 Feb; 26(2):123-30. PubMed ID: 8904521
[TBL] [Abstract][Full Text] [Related]
13. Hepcidin as a potential biomarker for blood doping.
Leuenberger N; Bulla E; Salamin O; Nicoli R; Robinson N; Baume N; Saugy M
Drug Test Anal; 2017 Jul; 9(7):1093-1097. PubMed ID: 27758046
[TBL] [Abstract][Full Text] [Related]
14. Intravenous versus oral iron supplementation for preoperative stimulation of hemoglobin synthesis using recombinant human erythropoietin.
Rohling RG; Zimmermann AP; Breymann C
J Hematother Stem Cell Res; 2000 Aug; 9(4):497-500. PubMed ID: 10982248
[TBL] [Abstract][Full Text] [Related]
15. Effects of subcutaneous recombinant human erythropoietin in normal subjects: development of decreased reticulocyte hemoglobin content and iron-deficient erythropoiesis.
Brugnara C; Colella GM; Cremins J; Langley RC; Schneider TJ; Rutherford CJ; Goldberg MA
J Lab Clin Med; 1994 May; 123(5):660-7. PubMed ID: 8195672
[TBL] [Abstract][Full Text] [Related]
16. Effect of recombinant human erythropoietin treatment on blood pressure and some haematological parameters in healthy men.
Berglund B; Ekblom B
J Intern Med; 1991 Feb; 229(2):125-30. PubMed ID: 1997637
[TBL] [Abstract][Full Text] [Related]
17. Reticulocyte changes after experimental anemia and erythropoietin treatment of horses.
Cooper C; Sears W; Bienzle D
J Appl Physiol (1985); 2005 Sep; 99(3):915-21. PubMed ID: 16103516
[TBL] [Abstract][Full Text] [Related]
18. Tracking immature reticulocyte proteins for improved detection of recombinant human erythropoietin (rhEPO) abuse.
Cox HD; Miller GD; Manandhar A; Husk JD; Crouch AK; Eichner D
Am J Hematol; 2021 Dec; 96(12):1621-1629. PubMed ID: 34626008
[TBL] [Abstract][Full Text] [Related]
19. Dose-dependent effects of recombinant human erythropoietin on the reticulocyte population of rabbits.
Fuchs A; Eder H
Arzneimittelforschung; 1992 Oct; 42(10):1266-8. PubMed ID: 1472149
[TBL] [Abstract][Full Text] [Related]
20. Use of reticulocyte cellular indices in the diagnosis and treatment of hematological disorders.
Brugnara C
Int J Clin Lab Res; 1998; 28(1):1-11. PubMed ID: 9594357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
